Metabolomics reveals broad-scale metabolic perturbations in hyperglycemic mothers during pregnancy.

PubWeight™: 1.35‹?› | Rank: Top 10%

🔗 View Article (PMC 3867997)

Published in Diabetes Care on August 29, 2013

Authors

Denise M Scholtens1, Michael J Muehlbauer, Natalie R Daya, Robert D Stevens, Alan R Dyer, Lynn P Lowe, Boyd E Metzger, Christopher B Newgard, James R Bain, William L Lowe, HAPO Study Cooperative Research Group

Author Affiliations

1: Corresponding author: Denise M. Scholtens, dscholtens@northwestern.edu.

Articles citing this

Sialylated Milk Oligosaccharides Promote Microbiota-Dependent Growth in Models of Infant Undernutrition. Cell (2016) 2.06

Genetics, genomics and metabolomics: new insights into maternal metabolism during pregnancy. Diabet Med (2014) 0.94

New insights into gestational glucose metabolism: lessons learned from 21st century approaches. Diabetes (2015) 0.90

Longitudinal Metabolomic Profiling of Amino Acids and Lipids across Healthy Pregnancy. PLoS One (2015) 0.88

Diet-induced changes in maternal gut microbiota and metabolomic profiles influence programming of offspring obesity risk in rats. Sci Rep (2016) 0.83

Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health. Front Microbiol (2016) 0.83

Maternal Early Pregnancy Serum Metabolites and Risk of Gestational Diabetes Mellitus. J Clin Endocrinol Metab (2015) 0.82

Metabolomics and Metabolic Diseases: Where Do We Stand? Cell Metab (2016) 0.81

Cumulative consumption of branched-chain amino acids and incidence of type 2 diabetes. Int J Epidemiol (2016) 0.81

Metabomxtr: an R package for mixture-model analysis of non-targeted metabolomics data. Bioinformatics (2014) 0.80

Metabolic Networks and Metabolites Underlie Associations Between Maternal Glucose During Pregnancy and Newborn Size at Birth. Diabetes (2016) 0.79

Metabolomic and Gene Expression Profiles Exhibit Modular Genetic and Dietary Structure Linking Metabolic Syndrome Phenotypes in Drosophila. G3 (Bethesda) (2015) 0.78

Associations of maternal BMI and insulin resistance with the maternal metabolome and newborn outcomes. Diabetologia (2016) 0.77

Human amylin proteotoxicity impairs protein biosynthesis, and alters major cellular signaling pathways in the heart, brain and liver of humanized diabetic rat model in vivo. Metabolomics (2016) 0.76

Metabolomics in the developmental origins of obesity and its cardiometabolic consequences. J Dev Orig Health Dis (2015) 0.76

Influence of the time of day and fasting duration on glucose level following a 1-hour, 50-gram glucose challenge test in pregnant women. PLoS One (2014) 0.75

The chromosome 3q25 locus associated with fetal adiposity is not associated with childhood adiposity. Nutr Diabetes (2014) 0.75

Intersection of complex genetic traits affecting maternal metabolism, fetal metabolism, and neural tube defect risk: looking for needles in multiple haystacks. Mol Genet Metab (2014) 0.75

Amino acid profiling in the gestational diabetes mellitus. J Diabetes Metab Disord (2017) 0.75

Maternal urinary metabolic signatures of fetal growth and associated clinical and environmental factors in the INMA study. BMC Med (2016) 0.75

Early Antenatal Prediction of Gestational Diabetes in Obese Women: Development of Prediction Tools for Targeted Intervention. PLoS One (2016) 0.75

An Unbiased Lipidomics Approach Identifies Early Second Trimester Lipids Predictive of Maternal Glycemic Traits and Gestational Diabetes Mellitus. Diabetes Care (2016) 0.75

Mixture model normalization for non-targeted gas chromatography/mass spectrometry metabolomics data. BMC Bioinformatics (2017) 0.75

Lactation is associated with altered metabolomic signatures in women with gestational diabetes. Diabetologia (2016) 0.75

Metabolomics of Diabetes in Pregnancy. Curr Diab Rep (2017) 0.75

Articles cited by this

Hyperglycemia and adverse pregnancy outcomes. N Engl J Med (2008) 25.36

International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care (2010) 18.00

Metabolite profiles and the risk of developing diabetes. Nat Med (2011) 12.22

A global test for groups of genes: testing association with a clinical outcome. Bioinformatics (2004) 10.82

Selective versus total insulin resistance: a pathogenic paradox. Cell Metab (2008) 5.25

Gestational diabetes mellitus. J Clin Invest (2005) 4.60

FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. Anal Chem (2009) 3.71

Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab (2012) 3.26

Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest (2011) 3.23

Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. Sci Transl Med (2011) 3.20

alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One (2010) 2.94

Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One (2010) 2.84

Metabolomics applied to diabetes research: moving from information to knowledge. Diabetes (2009) 2.68

The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care (2012) 2.61

The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Int J Gynaecol Obstet (2002) 2.58

UniPathway: a resource for the exploration and annotation of metabolic pathways. Nucleic Acids Res (2011) 2.45

Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr (2000) 2.44

Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care (2008) 2.22

Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. PLoS One (2010) 2.14

Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance. Diabet Med (2005) 2.10

Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss. Diabetologia (2011) 1.93

A mixture model with detection limits for regression analyses of antibody response to vaccine. Biometrics (1995) 1.87

Metabolic signatures of insulin resistance in 7,098 young adults. Diabetes (2012) 1.80

Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9,369 Finnish men. Diabetes (2012) 1.78

The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care (2007) 1.54

The Chemical Translation Service--a web-based tool to improve standardization of metabolomic reports. Bioinformatics (2010) 1.51

Deconvolution gas chromatography/mass spectrometry of urinary organic acids--potential for pattern recognition and automated identification of metabolic disorders. Rapid Commun Mass Spectrom (1999) 1.45

The STEDMAN project: biophysical, biochemical and metabolic effects of a behavioral weight loss intervention during weight loss, maintenance, and regain. OMICS (2009) 1.43

Insulin resistance and the metabolism of branched-chain amino acids in humans. Amino Acids (2011) 1.25

Maternal and fetal amino acid concentrations in normal pregnancies and in pregnancies with gestational diabetes mellitus. Am J Obstet Gynecol (2005) 1.12

Metabolic biomarkers of prenatal disorders: an exploratory NMR metabonomics study of second trimester maternal urine and blood plasma. J Proteome Res (2011) 1.11

Effects of gestational diabetes on diurnal profiles of plasma glucose, lipids, and individual amino acids. Diabetes Care (1980) 1.11

The roles of glycated albumin as intermediate glycation index and pathogenic protein. Diabetes Metab J (2012) 1.09

Normal and abnormal maternal metabolism during pregnancy. Semin Fetal Neonatal Med (2008) 1.02

UPLC-MS metabolic profiling of second trimester amniotic fluid and maternal urine and comparison with NMR spectral profiling for the identification of pregnancy disorder biomarkers. Mol Biosyst (2012) 0.99

Metabolic changes in urine during and after pregnancy in a large, multiethnic population-based cohort study of gestational diabetes. PLoS One (2012) 0.98

Protein metabolism in pregnancy. Am J Clin Nutr (2000) 0.94

Estimates of insulin sensitivity using glucose and C-Peptide from the hyperglycemia and adverse pregnancy outcome glucose tolerance test. Diabetes Care (2009) 0.87

1,5-Anhydroglucitol as a marker of maternal glycaemic control and predictor of neonatal birthweight in pregnancies complicated by type 1 diabetes mellitus. Diabetologia (2013) 0.80

Articles by these authors

Hyperglycemia and adverse pregnancy outcomes. N Engl J Med (2008) 25.36

International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care (2010) 18.00

A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab (2009) 11.46

Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab (2008) 9.74

Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science (2013) 8.81

Association of weight status with mortality in adults with incident diabetes. JAMA (2012) 7.49

Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA (2003) 7.35

SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature (2010) 6.48

Mechanisms of disease:Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol (2008) 6.23

Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat Med (2004) 5.04

Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes (2008) 4.77

Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab (2007) 4.51

Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J Biol Chem (2005) 4.30

Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab (2008) 4.29

The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med (2011) 4.24

Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genome-wide association study. J Am Med Inform Assoc (2011) 4.20

Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. J Biol Chem (2003) 4.12

Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell (2005) 4.04

Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabetes Care (2009) 3.69

Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet (2012) 3.68

Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science (2012) 3.52

Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation (2004) 3.44

SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol Cell (2011) 3.33

Leptin therapy in insulin-deficient type I diabetes. Proc Natl Acad Sci U S A (2010) 3.23

A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nat Med (2002) 3.22

Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. Sci Transl Med (2011) 3.20

Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease. Science (2008) 3.17

Obesity-related derangements in metabolic regulation. Annu Rev Biochem (2006) 3.14

Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study: associations with maternal body mass index. BJOG (2010) 3.11

Hypothalamic CaMKK2 contributes to the regulation of energy balance. Cell Metab (2008) 3.04

Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem (2011) 2.82

Continuous electroencephalographic monitoring in critically ill patients: indications, limitations, and strategies. Crit Care Med (2013) 2.79

Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care (2011) 2.75

Metabolomics applied to diabetes research: moving from information to knowledge. Diabetes (2009) 2.68

Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling. PLoS Genet (2008) 2.63

The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care (2012) 2.61

The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Int J Gynaecol Obstet (2002) 2.58

Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice. Science (2013) 2.49

Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality. JAMA (2004) 2.45

Dissecting the in vivo metabolic potential of two human gut acetogens. J Biol Chem (2010) 2.42

Nitric oxide represses the Arabidopsis floral transition. Science (2004) 2.41

Midlife body mass index and hospitalization and mortality in older age. JAMA (2006) 2.36

Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events. Circ Cardiovasc Genet (2010) 2.34

Presence and severity of intensive care unit-acquired paresis at time of awakening are associated with increased intensive care unit and hospital mortality. Crit Care Med (2009) 2.31

Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care (2012) 2.29

Sugar-sweetened beverage, sugar intake of individuals, and their blood pressure: international study of macro/micronutrients and blood pressure. Hypertension (2011) 2.29

Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control. J Biol Chem (2009) 2.28

Prospective evaluation of pain and analgesic use following major elective intracranial surgery. J Neurosurg (2007) 2.26

Mortality in patients with necrotizing fasciitis. Plast Reconstr Surg (2007) 2.25

High heritability of metabolomic profiles in families burdened with premature cardiovascular disease. Mol Syst Biol (2009) 2.21

PGC-1beta in the regulation of hepatic glucose and energy metabolism. J Biol Chem (2003) 2.20

Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility. Cell Metab (2012) 2.11

Acute lung injury in critical neurological illness. Crit Care Med (2012) 2.09

13C NMR isotopomer analysis reveals a connection between pyruvate cycling and glucose-stimulated insulin secretion (GSIS). Proc Natl Acad Sci U S A (2002) 2.04

A pyruvate cycling pathway involving cytosolic NADP-dependent isocitrate dehydrogenase regulates glucose-stimulated insulin secretion. J Biol Chem (2006) 2.03

Metabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia/reperfusion. Circulation (2009) 2.01